Literature DB >> 21913336

Muscarinic receptor subtypes as potential targets to modulate oligodendrocyte progenitor survival, proliferation, and differentiation.

Federica De Angelis1, Antonietta Bernardo, Valerio Magnaghi, Luisa Minghetti, Ada Maria Tata.   

Abstract

Acetylcholine (ACh) is a major neurotransmitter but also an important signaling molecule in neuron-glia interactions. Expression of ACh receptors has been reported in several glial cell populations, including oligodendrocytes (OLs). Nonetheless, the characterization of muscarinic receptors in these cells, as well as the description of the cholinergic effects at different stages of OL development, is still incomplete. In this study, we characterized the pattern of expression of muscarinic receptor subtypes in primary cultures of rat oligodendrocyte progenitor cells (OPC) and mature OLs, at both mRNA and protein levels. We found that muscarinic receptor expression is developmentally regulated. M1, M3, and M4 receptors were the main subtypes expressed in OPC, whereas all receptor subtypes were expressed at low levels in mature OLs. Exposure of OPC to muscarine enhanced cell proliferation, an effect mainly due to M1, M3, and M4 receptor subtypes as demonstrated by pharmacological competition with selective antagonists. Conversely, M2 receptor activation impaired OPC survival. In line with the mitogenic activity, muscarinic receptor activation increased the expression of platelet derived growth factor receptor α. Muscarine stimulation increased CX32 and myelin basic protein expression, left unaffected that of myelin proteolipid protein (PLP), and decreased member of the family of epidermal growth factor receptor (EGFR) ErbB3/ErbB4 receptor expression indicating a predominant role of muscarinic receptors in OPC. These findings suggest that ACh may contribute to the maintenance of an immature proliferating progenitor pool and impair the progression toward mature stage. This hypothesis is further supported by increased expression of Notch-1 in OL on muscarinic activation.
Copyright © 2011 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 21913336     DOI: 10.1002/dneu.20976

Source DB:  PubMed          Journal:  Dev Neurobiol        ISSN: 1932-8451            Impact factor:   3.964


  43 in total

1.  Multiple sclerosis: An old drug plays a new trick.

Authors:  Hartmut Wekerle; Edgar Meinl
Journal:  Nature       Date:  2013-10-09       Impact factor: 49.962

2.  Muscarinic Receptor M3R Signaling Prevents Efficient Remyelination by Human and Mouse Oligodendrocyte Progenitor Cells.

Authors:  R Ross Welliver; Jessie J Polanco; Richard A Seidman; Anjali K Sinha; Melanie A O'Bara; Zainab M Khaku; Diara A Santiago González; Akiko Nishiyama; Jurgen Wess; M Laura Feltri; Pablo M Paez; Fraser J Sim
Journal:  J Neurosci       Date:  2018-06-29       Impact factor: 6.167

3.  Sleep and oligodendrocyte functions.

Authors:  Michele Bellesi
Journal:  Curr Sleep Med Rep       Date:  2015-03-01

Review 4.  Differential Modulators of NG2-Glia Differentiation into Neurons and Glia and Their Crosstalk.

Authors:  Xiaohuang Du; Zuo Zhang; Hongli Zhou; Jiyin Zhou
Journal:  Cell Mol Neurobiol       Date:  2020-04-13       Impact factor: 5.046

5.  Cholinergic activation of enteric glia is a physiological mechanism that contributes to the regulation of gastrointestinal motility.

Authors:  Ninotchska M Delvalle; David E Fried; Gretchen Rivera-Lopez; Luke Gaudette; Brian D Gulbransen
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2018-06-21       Impact factor: 4.052

Review 6.  Remyelination Pharmacotherapy Investigations Highlight Diverse Mechanisms Underlying Multiple Sclerosis Progression.

Authors:  George S Melchor; Tahiyana Khan; Joan F Reger; Jeffrey K Huang
Journal:  ACS Pharmacol Transl Sci       Date:  2019-11-14

7.  Micropillar arrays as a high-throughput screening platform for therapeutics in multiple sclerosis.

Authors:  Feng Mei; Stephen P J Fancy; Yun-An A Shen; Jianqin Niu; Chao Zhao; Bryan Presley; Edna Miao; Seonok Lee; Sonia R Mayoral; Stephanie A Redmond; Ainhoa Etxeberria; Lan Xiao; Robin J M Franklin; Ari Green; Stephen L Hauser; Jonah R Chan
Journal:  Nat Med       Date:  2014-07-06       Impact factor: 53.440

Review 8.  New pharmacological approaches to the cholinergic system: an overview on muscarinic receptor ligands and cholinesterase inhibitors.

Authors:  Nigel H Greig; Marcella Reale; Ada M Tata
Journal:  Recent Pat CNS Drug Discov       Date:  2013-08

9.  A regenerative approach to the treatment of multiple sclerosis.

Authors:  Brian R Lawson; Peter G Schultz; Luke L Lairson; Vishal A Deshmukh; Virginie Tardif; Costas A Lyssiotis; Chelsea C Green; Bilal Kerman; Hyung Joon Kim; Krishnan Padmanabhan; Jonathan G Swoboda; Insha Ahmad; Toru Kondo; Fred H Gage; Argyrios N Theofilopoulos
Journal:  Nature       Date:  2013-10-09       Impact factor: 49.962

10.  Clemastine Enhances Myelination in the Prefrontal Cortex and Rescues Behavioral Changes in Socially Isolated Mice.

Authors:  Jia Liu; Jeffrey L Dupree; Mar Gacias; Rebecca Frawley; Tamjeed Sikder; Payal Naik; Patrizia Casaccia
Journal:  J Neurosci       Date:  2016-01-20       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.